Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Pituitary-region mass and visual-field loss

Essential points for quick revision.

Saved on this device
!
Pituitary apoplexy with visual or haemodynamic compromise

Sudden severe headache with vomiting, reduced acuity, a new field defect, ophthalmoplegia or reduced consciousness may be haemorrhage or infarction in a pituitary tumour. Hypotension, hyponatraemia or hypoglycaemia may indicate acute ACTH–cortisol failure.

Action: Stabilise airway, breathing and circulation, obtain urgent bloods including cortisol if this does not delay treatment, give empirical adult hydrocortisone when Society for Endocrinology criteria are present, obtain urgent MRI or pituitary CT if MRI is impossible, and refer immediately to the joint neurosurgical–endocrine team.

Synopsis

Recognise optic-chiasm compression and pituitary dysfunction, investigate a sellar or suprasellar mass safely, and distinguish planned multidisciplinary care from pituitary apoplexy with threatened vision or adrenal crisis.

  • A pituitary-region mass may compress the optic chiasm, disturb anterior or posterior pituitary function, invade the cavernous sinus or be discovered incidentally; imaging appearance alone does not establish the lesion type.
  • Chiasmal compression classically causes bitemporal field loss, but acuity can remain normal early and patterns vary with the direction of compression; test each eye formally rather than relying on confrontation alone.
  • Pituitary apoplexy is an adult neuroendocrine emergency: acute headache plus neuro-ophthalmic or consciousness change requires resuscitation, urgent endocrine–neurosurgical contact, MRI and timely hydrocortisone when indicated.

Key red flags

Abrupt severe headache with reduced visual acuity, a new visual-field defect, diplopia, ptosis, ophthalmoplegia or reduced consciousness: suspect pituitary apoplexy.

Haemodynamic instability, altered consciousness, reduced acuity or a severe field defect in suspected adult apoplexy: these are explicit indications for empirical hydrocortisone replacement.

Rapidly progressive bitemporal or junctional field loss, optic-disc pallor or declining acuity suggests threatened optic pathway function and needs urgent specialist assessment.

Hypotension, vomiting, hyponatraemia or hypoglycaemia with a pituitary mass may be cortisol deficiency; do not attribute every symptom to raised intracranial pressure.

Polyuria and polydipsia can indicate posterior pituitary or stalk involvement and make a simple pituitary adenoma less certain; measure paired serum and urine indices and seek endocrine advice.

Fever, meningism, thunderclap headache or a third-nerve palsy also raises subarachnoid haemorrhage, meningitis or cavernous-sinus pathology, which must be assessed in parallel.

Chiasmal visual syndrome

Ask about bumping into doorframes, difficulty noticing traffic or people to either side, reading problems and loss of confidence driving. Check acuity, colour vision, pupils, confrontation fields, fundi and ocular movements; arrange formal perimetry because early bitemporal loss may escape bedside testing.

Pituitary apoplexy

Consider apoplexy in acute severe headache with neuro-ophthalmic signs, known pituitary tumour, meningism or reduced consciousness. Do not wait for the entire syndrome: threatened vision or haemodynamic compromise is enough to activate emergency endocrine and neurosurgical care.

Investigation priorities

01
Formal visual acuity, colour vision and automated perimetryFirst step

Quantify optic nerve and chiasm function in each eye and create a baseline for urgent decisions and follow-up.

Management branches

Emergency apoplexy pathwayAcute headache with visual compromise

An adult develops sudden severe headache, vomiting, a severe new field defect and hypotension with a sellar mass.

  1. Resuscitate and check glucose, neurological state, acuity, fields and ocular movements; call the joint endocrine–neurosurgical service immediately and treat competing SAH or meningitis pathways when indicated.
  2. Draw urgent safety bloods and pituitary samples if immediately feasible, then give empirical adult hydrocortisone because haemodynamic instability and severe visual loss meet Society for Endocrinology criteria; do not wait for cortisol results.
Stable mass pathwayProgressive bitemporal field loss

A stable adult has several months of peripheral visual loss and MRI shows a suprasellar pituitary-region mass contacting the chiasm.

Key medicines

Hydrocortisone for adult pituitary apoplexyWhen empirical replacement is indicated, Society for Endocrinology guidance allows 100 mg IM followed by 50–100 mg IM every 6 hours, or 100–200 mg IV followed by a continuous infusion of 2–4 mg/hour.Do not delay for cortisol sampling in an unstable or visually threatened patient. Monitor glucose, sodium, potassium, fluid balance and haemodynamics, then obtain endocrine advice for conversion and taper; this regimen is not the dexamethasone regimen for tumour-related vasogenic oedema.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 13 Sept 2026; clinical approval remains outstanding.

  • Society for Endocrinology emergency management of pituitary apoplexyEndocrine Connections 2016 emergency guidance; Introduction, Clinical presentation, Differential diagnosis, Management and After emergency care read. Adult initial-phase guidance supporting hydrocortisone indications/regimens, visual assessment, MRI and urgent joint referral.
  • Endocrine Society pituitary incidentaloma guidelinePublished 2011; current official guideline page checked 13 September 2026. Recommendations 1.1.1–1.1.3, 2.1 and 3.1 read for endocrine evaluation, formal visual fields, MRI follow-up and surgical referral; incidental adult lesion scope, not acute apoplexy.
  • Pituitary Society international incidentaloma consensus statementVersion of record 24 June 2025; abstract and accessible consensus scope read for individualised imaging, endocrine, visual and specialist assessment, including age-specific contexts. Detailed recommendations were not inferred from the abstract.
Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom